RecruitingPhase 1 / Phase 2NCT05761899
Respiratory
Hereditary pulmonary alveolar proteinosis
2
studies recruiting now
as of 7 Sept 2026
4
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
9 Mar 2023
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT02852928
European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Hereditary pulmonary alveolar proteinosis studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Hereditary pulmonary alveolar proteinosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Hereditary pulmonary alveolar proteinosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (CSF2RB, CSF2RA).
Treatments being studied
1 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Sargramostim (Leukine)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).